Biomea Fusion BMEA
NASDAQ BMEA
$1.37 +0.01 (+0.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biomea Fusion (BMEA) Current Assets (2020 - 2026)

Biomea Fusion (BMEA) posted Current Assets of $46.3 million for Q1 2026, down 20.21% sequentially from $58.0 million in Q4 2025, and up 3.65% YoY from $44.7 million in Q1 2025.

Biomea Fusion (BMEA) Current Assets (2020 - 2026) Analysis & Trends

Biomea Fusion has reported Current Assets for 7 years, with the latest figure at $46.3 million in Q1 2026.

  • Quarterly Current Assets rose 3.65% year-over-year to $46.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46.3 million (up 3.65% YoY) and the FY2025 annual result came in at $58.0 million, down 15.05% from the prior year.
  • Current Assets slipped to $46.3 million in Q1 2026 per BMEA's latest filing, from $58.0 million in the prior quarter.
  • Over five years, Current Assets peaked at $225.9 million in Q2 2023 and troughed at $44.7 million in Q1 2025.
  • A 5-year average of $115.5 million and a median of $116.3 million in 2024 frame the typical range for Current Assets.
  • The sharpest annual moves came in 2022 and 2025: Current Assets surged 251.46% in 2022, then sank 69.72% in 2025.
  • Over 5 years, Current Assets stood at $117.8 million in 2022, then jumped by 52.08% to $179.2 million in 2023, then tumbled by 61.86% to $68.3 million in 2024, then dropped by 15.05% to $58.0 million in 2025, then slipped by 20.21% to $46.3 million in 2026.
  • According to Business Quant data, Current Assets over the past three periods registered $46.3 million, $58.0 million, and $49.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 12.54 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 18.45 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 8.07 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 5.82 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 7.22 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 4.62 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 18.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.63 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 1.76 Bn
10 Biomea Fusion 97.69 Mn 97.69 Mn - 36.43 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 36.43 Mn
Mar 31, 2026 46.32 Mn
Dec 31, 2025 58.05 Mn
Sep 30, 2025 49.44 Mn
Jun 30, 2025 64.66 Mn
Mar 31, 2025 44.69 Mn
Dec 31, 2024 68.33 Mn
Sep 30, 2024 93.60 Mn
Jun 30, 2024 116.29 Mn
Mar 31, 2024 147.57 Mn
Dec 31, 2023 179.18 Mn
Sep 30, 2023 202.50 Mn
Jun 30, 2023 225.94 Mn
Mar 31, 2023 88.93 Mn
Dec 31, 2022 117.82 Mn
Sep 30, 2022 138.86 Mn
Jun 30, 2022 154.14 Mn
Mar 31, 2022 167.02 Mn
Dec 31, 2021 176.56 Mn
Sep 30, 2021 191.10 Mn